Valneva SE is a French biotech company headquartered in Saint-Herblain, France, developing and commercializing vaccines for infectious diseases. It has... 12 KB (997 words) - 22:21, 31 December 2023 |
 | Valneva COVID-19 vaccine is a COVID-19 vaccine developed by French biotechnology company Valneva SE in collaboration with the American biopharmaceutical... 18 KB (1,318 words) - 13:22, 28 March 2024 |
against infectious diseases. The company merged with Vivalis to form Valneva SE in 2012. Intercell was formed in 1998 as a spin-off of the Research Institute... 7 KB (436 words) - 17:19, 13 March 2024 |
"Covid-19: UK orders extra 40m doses of Valneva vaccine". BBC News. 1 February 2021. Archived from the original on 3 February 2021. Retrieved 1 February... 347 KB (33,588 words) - 08:02, 5 April 2024 |
based rabies vaccine approved by the World Health Organization. Ixiaro by Valneva SE for Japanese encephalitis. Audsley JM, Tannock GA (1 August 2008). "Cell-based... 16 KB (1,533 words) - 02:48, 30 January 2023 |
Kingdom United States VLA2001 is an inactivated vaccine developed by Valneva SE and Dynavax Technologies. Full (1) United Kingdom Emergency (32) Bahrain... 318 KB (19,351 words) - 20:00, 21 April 2024 |
Union Technologies Informatique Group Valneva SE Verimatrix Vilmorin & Cie Voluntis Wavestone X-FAB Silicon Foundries SE Xilam Animation Ymagis CAC 40 CAC... 5 KB (481 words) - 13:31, 27 December 2023 |
 | their offices and warehouse is located in Livingston at Navigation House. Valneva SE is a biotech company that has a manufacturing facility in Livingston which... 77 KB (7,786 words) - 02:50, 15 March 2024 |
 | technology. In July 2019, US$23.4 million was given to Austrian-based biotech Valneva SE to fund manufacturing and late-stage clinical development of a single-dose... 56 KB (5,131 words) - 09:16, 18 April 2024 |
| LNP-nCoVsaRNA, Novavax NVX-CoV2373, Janssen Pharmaceutica Ad26.COV2.S, and Valneva SE VLA2001. Kobie, Nicole (February 15, 2020). "This is how the UK is strengthening... 101 KB (10,258 words) - 10:42, 11 January 2024 |
 | BioNTech (redirect from BioNTech SE) possible COVID-19 vaccine doses from Pfizer/BioNTech, Valneva". Reuters. London. Retrieved 2 August 2020. SE, BioNTech (5 August 2020). "Pfizer and BioNTech... 40 KB (3,633 words) - 02:16, 24 March 2024 |
 | extra 40 million doses of VLA2001, a vaccine from French biotech company Valneva SE, for availability later in the year and into 2022. The Isle of Man government... 301 KB (37,263 words) - 04:56, 1 April 2024 |
COVID-19 vaccines from several pharmaceutical companies including Pfizer, Valneva SE and BioNTech. The British government has already secured 100 million doses... 342 KB (32,802 words) - 09:34, 15 November 2023 |
Medicago, Merck, Pfizer, Public Health Ontario, Sanofi Pasteur, Seqirus and Valneva SE. Notable presenters include Dr. Shelley Deeks, Chair of the National Advisory... 9 KB (727 words) - 17:48, 25 August 2023 |
 | PMID 22184691. McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, et al. (March 2018). "Clinical Practice Guidelines for Clostridium difficile... 98 KB (10,355 words) - 04:39, 1 April 2024 |
doi:10.1038/ni928. PMID 12730692. S2CID 26642061. Mempel TR, Henrickson SE, Von Andrian UH (January 2004). "T-cell priming by dendritic cells in lymph... 37 KB (4,220 words) - 10:13, 27 March 2024 |
 | Malik M, Berelowitz M, Dhillon AP, Thomson MA, Harvey P, Valentine A, Davies SE, Walker-Smith JA (February 1998). "Ileal-lymphoid-nodular hyperplasia, non-specific... 96 KB (9,862 words) - 12:28, 5 April 2024 |
 | (OspA) protein subunit-based vaccine candidate VLA15 was developed by Valneva. It was granted fast track designation by the U.S. Food and Drug Administration... 224 KB (23,796 words) - 19:55, 28 March 2024 |
 | PMID 33951357. Chung H, He S, Nasreen S, Sundaram ME, Buchan SA, Wilson SE, et al. (August 2021). "Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines... 236 KB (19,394 words) - 05:58, 20 April 2024 |
 | 45: 2–3. doi:10.1086/520068. Kim NH, Lee J, Lee SJ, Lee H, Kim KH, Park SE, et al. (November 2007). "Immunogenicity and safety of pneumococcal 7-valent... 15 KB (1,249 words) - 14:09, 27 January 2024 |
 | "Les virus, comme les parasites, se multiplient eux-même, nous ne leur fournissons que les moyens de vivre et de se reproduire, jamais nous les créons... 77 KB (7,918 words) - 19:54, 20 March 2024 |
 | doi:10.1007/BF01983415. PMID 8088305. S2CID 43300463. Fullerton KE, Reef SE (October 2002). "Commentary: Ongoing debate over the safety of the different... 56 KB (5,189 words) - 16:28, 2 March 2024 |
 | July 2022. "Vaiolo delle scimmie, 'abbiamo 5 milioni dosi di vaccino: pronti se servirà'" (in Italian). adnkronos. 27 May 2022. Archived from the original... 112 KB (12,132 words) - 09:38, 14 April 2024 |
and the Iranian COVIran Barekat. Vaccines in clinical trials include the Valneva COVID‑19 vaccine.[unreliable source?] Subunit vaccines present one or more... 192 KB (21,930 words) - 19:29, 15 April 2024 |
 | "Wastewater use in agriculture: public health considerations.". In Jorgensen SE (ed.). Encyclopedia of Water Science (2nd ed.). Boca Raton: CRC Press. doi:10... 61 KB (5,245 words) - 17:47, 3 December 2023 |
 | incorporates text from this source, which is in the public domain. Oliver SE, Moore KL (6 February 2020). "Licensure of a Diphtheria and Tetanus Toxoids... 14 KB (1,021 words) - 18:26, 16 September 2023 |
 | 1016/S0140-6736(15)60721-8. PMC 5626001. PMID 25913272. Swearingen KE, Lindner SE, Shi L, Shears MJ, Harupa A, Hopp CS, et al. (April 2016). "Interrogating... 25 KB (2,323 words) - 07:15, 11 March 2024 |
 | Retrieved 16 June 2021. "Da la Cofepris autorización para que la vacuna Sputnik V se aplique en México". Diario de Yucatán (in Spanish). 2 February 2021. Archived... 154 KB (13,880 words) - 13:52, 20 April 2024 |
| stage for testing the vaccine on humans. "Dự kiến cuối quý 3-2021, Việt Nam sẽ có vaccine phòng Covid-19 đầu tiên" [It is expected that at the end of the... 7 KB (668 words) - 20:53, 27 September 2023 |
 | Archived from the original on 11 March 2021. Retrieved 16 March 2021. Oliver SE, Wallace M, See I, Mbaeyi S, Godfrey M, Hadler SC, et al. (January 2022).... 142 KB (11,316 words) - 14:22, 4 February 2024 |